Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Capex Is King: Morgan Stanley Bets On Defence, Large-Caps; But Crude Oil Is India's Achilles' Heel
Jonathan Garner, Chief Asia and Emerging Market Equity Strategist
India's earnings outlook is healthy, but AI boom draws global investors elsewhere: Morgan Stanley
Jonathan Garner, Chief Asia and Emerging Market Equity Strategist at Morgan Stanley, said passive funds that track benchmark indices are increasingly allocating capital to Taiwan and South Korea, where earnings momentum is strongest, while reducing exposure to India and China due to relatively weaker earnings growth.
10 stocks Morgan Stanley has rated ‘Overweight’. How many do you own?
Morgan Stanley remains constructive on Indian equities, citing improving earnings growth, supportive policies, healthy domestic inflows and attractive long-term prospects. The brokerage believes India is well placed for a sustained market upcycle and has identified 12 stocks across sectors that it expects to outperform as the growth cycle strengthens.
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block deal
Shares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece on Tuesday. Promoter-linked entities offloaded their stake, while domestic mutual funds and foreign institutional investors emerged as key buyers, signalling strong institutional participation. The company also launched semaglutide pre-filled syringes in India.
Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers
Alkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of domestic mutual funds and foreign institutional investors. This transaction occurred after a strong performance by Alkem Laboratories shares over the past year. The deal highlights continued institutional interest in the pharmaceutical sector.
Explained: Why Indian stock market has fallen prey to South Korea, Taiwan’s AI prowess
South Korea's stock market has surged past India's, becoming the world's sixth-largest, driven by its semiconductor giants' AI boom. India faces headwinds from a weakening rupee and lack of AI exposure. Despite current challenges, Morgan Stanley remains optimistic about India's long-term growth prospects, citing improving earnings and macro support.
Morgan Stanley says Indian stock market poised for strong year ahead. Here’s why
Morgan Stanley remains bullish on Indian equities, citing an earnings upcycle, supportive macroeconomic conditions and strong domestic flows. The brokerage expects sustained growth driven by investment, manufacturing and AI-linked opportunities, while highlighting external risks. It projects the Sensex could reach 89,000, supported by robust earnings growth and improving market fundamentals.
Stock market strategy: Sensex, Nifty fall 3-4% in 30 days but Morgan Stanley sees strong year ahead - Here's why - Business Today
Stock market strategy: Sensex, Nifty fall 3-4% in 30 days but Morgan Stanley sees strong year ahead - Here's whyBusiness Today
Morgan Stanley sees Reliance Industries’ AI, new energy bets powering next growth chapters. Here’s why
Morgan Stanley believes Reliance Industries has entered its fifth monetisation cycle, with artificial intelligence infrastructure and new energy businesses poised to become key growth drivers. Maintaining an overweight rating and a target price of Rs 1,803, the brokerage sees 34% upside in the stock.
PB Fintech shares in focus after founders sell stake worth Rs 665 crore in Policybazaar parent
PB Fintech founders sold shares worth Rs 665 crore. Yashish Dahiya and Alok Bansal offloaded stock on Friday. Major investors like Goldman Sachs and Morgan Stanley bought these shares. This follows previous stake sales by the founders. PB Fintech reported strong revenue and profit growth for the January-March quarter. The company's stock has seen significant fluctuations since its IPO.
Hindalco, Nalco shares jump up to 5% after aluminium prices hit 4-year high. Where is metal headed?
Hindalco and Nalco shares climbed as aluminium prices hit a four-year peak. Geopolitical tensions in Iran and possible production curbs in China, the world's top producer, are driving the rally. Traders are concerned about China's review of energy consumption and emissions. This situation tightens global supply, benefiting Indian aluminium producers. Morgan Stanley sees strong demand and constrained supply supporting prices.
The aluminium boom is here: Why Morgan Stanley says Hindalco is set to explode
Morgan Stanley initiated coverage on Hindalco Industries with an ‘Overweight’ rating and a target price of Rs 1,325, citing a favourable aluminium demand-supply outlook, strong free cash flow generation and India’s multi-year growth cycle. The brokerage believes Hindalco is well positioned for margin expansion and long-term value unlocking.